6BLR:
reference: C-terminal modification of the insulin B:11-23 peptide creates superagonists in mouse and human type 1 diabetes., Wang Y, Sosinowski T, Novikov A, Crawford F, Neau DB, Yang J, Kwok WW, Marrack P, Kappler JW, Dai S, Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1716527115. doi:, 10.1073/pnas.1716527115. PMID: 29255035

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).